INO
Inovio Pharmaceuticals Inc
1.20$
-3.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -11.5% | -24.5% | +3.6% | -20.0% | +5.7% | -22.9% | -21.8% | +1.7% | +7.1% | -33.0% | -0.8% | |
| – | -12.4% | -27.1% | +5.3% | -22.4% | +7.2% | -26.5% | -26.7% | +4.7% | +10.8% | -35.5% | +1.2% | |
| – | -23.9% | +37.0% | +75.5% | -36.9% | +203.5% | -39.4% | -39.0% | +50.2% | +21.1% | -40.7% | +20.0% | |
| – | -13.2% | -27.3% | +4.6% | -23.2% | +11.0% | -27.4% | -30.4% | +6.8% | +15.2% | -35.6% | -2.7% | |
| – | +12.2% | +6.1% | -30.5% | +5.0% | -35.6% | +9.3% | -35.9% | +16.5% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.4% | -35.3% | +6.9% | -9.5% | +33.3% | -19.4% | +10.2% | +94.2% | -34.9% | -13.0% | +3.0% | |
| – | -2.6% | -45.0% | +12.8% | -11.0% | +50.3% | -22.6% | +16.0% | +120.2% | -37.5% | -13.2% | +5.3% | |
| – | +3.1% | -88.8% | +7.7% | +4.4% | +3.0% | +3.1% | +3.1% | +3.1% | +3.1% | +3.1% | -0.4% | |
| – | +19.1% | +78.5% | -22.8% | -16.0% | +19.6% | -14.3% | -0.7% | +7.7% | -55.6% | -24.1% | +486.1% | |
| – | -15.1% | -19.5% | +2.4% | -24.0% | -6.8% | -25.2% | -44.3% | -127.1% | – | -74.8% | -28.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.8% | +2.2% | +16.8% | +3.5% | -3.5% | +0.0% | +43.0% | +34.4% | +32.3% | +0.2% | +18.1% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.